<DOC>
	<DOCNO>NCT00413179</DOCNO>
	<brief_summary>The purpose study conduct placebo control , double-blind randomize trial chronic oligoovulatory anovulatory , hyperandrogenic , infertility patient compare effect adjuvant metformin plus clomiphene citrate clomiphene citrate plus placebo pregnancy rate ovulation rate . We hypothesize combine metformin clomiphene citrate would result high ovulation pregnancy rate hyperandrogenic woman chronic oligoovulation anovulation sole etiology infertility unknown responsiveness clomiphene citrate .</brief_summary>
	<brief_title>The Effect Metformin Added Clomiphene Citrate Pregnancy Rates Hyperandrogenic , Chronic Oligoovulatory Anovulatory Women</brief_title>
	<detailed_description>Women polycystic ovary syndrome ( PCOS ) , define chronic oligoovulation anovulation hyperandrogenism , primarily treat clomiphene citrate first line therapy desire pregnancy . However , woman PCOS low expect pregnancy rate response clomiphene citrate . Approximately 20 % woman PCOS resistant clomiphene citrate . Subjects chronic oligoovulation anovulation hyperandrogenism ovulate 80 % time , pregnancy occur 40 % . The ideal initial treatment regimen woman PCOS desire pregnancy determine . Metformin ( Glucophage ; Bristol-Myers Squibb , Princeton , NJ ) insulin sensitizer lower serum insulin androgen level . Numerous case study , case series , retrospective study , non-placebo control prospective study , suggest improvement insulin sensitivity , spontaneous menses , ovulatory response pregnancy metformin give alone prior initiation ovulation induce agent woman chronic anovulation hyperandrogenism . However , conflict evidence literature regard effect metformin alone combination ovulation induce agent regard ovulation pregnancy rate prospective , randomized trial . Therefore , remain unknown use metformin plus clomiphene citrate non-selected , infertility patient PCOS improve ovulation pregnancy rate compare use clomiphene citrate alone . Women history infertility diagnose hyperandrogenic , oligoovulatory anovulatory cycle sole etiology infertility randomize receive clomiphene citrate 50 mg day 5-9 , plus metformin 500 mg three time daily versus clomiphene plus placebo . The dose clomiphene increase maximum dose 250 mg step-wise fashion ovulation confirm ovulation predictor kit . Once ovulation confirm subject continue ovulatory dose clomiphene 6 ovulatory cycle conception . Metformin placebo start cycle day one discontinue 8 day LH surge and/or cycle day 21 . A positive HCG , ovulation rate pregnancy outcome outcome measure .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Married Hyperandrogenic woman 1840 year old desire fertility demonstrate chronic anovulation oligoovulation Had patent fallopian tube whose partner normal semen analyse eligible enrollment study . Androgen secrete tumour Diabetes mellitus Thyroid abnormality Hyperprolactinemia Adult onset congenital adrenal hyperplasia Diminished ovarian reserve Subjects use hormonal medication two month prior start trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Polycystic Ovarian Syndrome</keyword>
	<keyword>Chronic Anovulation</keyword>
	<keyword>Chronic Oligoovulation</keyword>
	<keyword>Infertility</keyword>
	<keyword>Hyperandrogenism</keyword>
	<keyword>Metformin</keyword>
	<keyword>Ovulation induction</keyword>
</DOC>